https://arxiv.org/api/usBdf51pMVuFPZN1+2fDgd7vYUk2026-03-20T17:12:36Z25979015http://arxiv.org/abs/2503.13477v3Periodontal Bone Loss Analysis via Keypoint Detection With Heuristic Post-Processing2025-10-20T10:26:37ZThis study proposes a deep learning framework and annotation methodology for the automatic detection of periodontal bone loss landmarks, associated conditions, and staging. 192 periapical radiographs were collected and annotated with a stage agnostic methodology, labelling clinically relevant landmarks regardless of disease presence or extent. We propose a heuristic post-processing module that aligns predicted keypoints to tooth boundaries using an auxiliary instance segmentation model. An evaluation metric, Percentage of Relative Correct Keypoints (PRCK), is proposed to capture keypoint performance in dental imaging domains. Four donor pose estimation models were adapted with fine-tuning for our keypoint problem. Post-processing improved fine-grained localisation, raising average PRCK^{0.05} by +0.028, but reduced coarse performance for PRCK^{0.25} by -0.0523 and PRCK^{0.5} by -0.0345. Orientation estimation shows excellent performance for auxiliary segmentation when filtered with either stage 1 object detection model. Periodontal staging was detected sufficiently, with the best mesial and distal Dice scores of 0.508 and 0.489, while furcation involvement and widened periodontal ligament space tasks remained challenging due to scarce positive samples. Scalability is implied with similar validation and external set performance. The annotation methodology enables stage agnostic training with balanced representation across disease severities for some detection tasks. The PRCK metric provides a domain-specific alternative to generic pose metrics, while the heuristic post-processing module consistently corrected implausible predictions with occasional catastrophic failures. The proposed framework demonstrates the feasibility of clinically interpretable periodontal bone loss assessment, with potential to reduce diagnostic variability and clinician workload.2025-03-05T00:34:29Z18 pages, 7 tables, 9 figures, 1 equation, journal paper submitted to Computers in Biology and MedicineRyan BanksVishal ThenganeMaría Eugenia GuerreroNelly Maria García-MadueñoYunpeng LiHongying TangAkhilanand Chaurasiahttp://arxiv.org/abs/2510.07653v2Large-scale spatial variable gene atlas for spatial transcriptomics2025-10-19T00:10:16ZSpatial variable genes (SVGs) reveal critical information about tissue architecture, cellular interactions, and disease microenvironments. As spatial transcriptomics (ST) technologies proliferate, accurately identifying SVGs across diverse platforms, tissue types, and disease contexts has become both a major opportunity and a significant computational challenge. Here, we present a comprehensive benchmarking study of 20 state-of-the-art SVG detection methods using human slides from STimage-1K4M, a large-scale resource of ST data comprising 662 slides from more than 18 tissue types. We evaluate each method across a range of biologically and technically meaningful criteria, including recovery of pathologist-annotated domain-specific markers, cross-slide reproducibility, scalability to high-resolution data, and robustness to technical variation. Our results reveal marked differences in performance depending on tissue type, spatial resolution, and study design. Beyond benchmarking, we construct the first cross-tissue atlas of SVGs, enabling comparative analysis of spatial gene programs across cancer and normal tissues. We observe similarities between pairs of tissues that reflect developmental and functional relationships, such as high overlap between thymus and lymph node, and uncover spatial gene programs associated with metastasis, immune infiltration, and tissue-of-origin identity in cancer. Together, our work defines a framework for evaluating and interpreting spatial gene expression and establishes a reference resource for the ST community.2025-10-09T01:03:58ZJiawen ChenJinwei ZhangDongshen PengYutong SongAitong RuanYun LiDidong Lihttp://arxiv.org/abs/2510.24752v1Mechanically Regulated Cranial Growth in Infancy: A Computational Approach to Predicting Craniosynostosis2025-10-17T12:15:13ZIn early years of life, the cranium rapidly changes in size and shape to accommodate brain growth, primarily driven by mechanical stress from brain expansion. Developmental disorders such as premature fusion of sutures in craniosynostosis, disrupts normal growth process, leading to abnormal skull shapes. Thus, understanding the interplay between biomechanical forces, soft tissues, and individual bone plates is crucial for understanding their role in shaping infant skulls. This study develops a mechanically-driven growth model to simulate healthy cranial growth in the first year. The algorithm considers simultaneous and coupled growth of brain, cranial bones, sutures, with volumetric brain expansion as the primary driver, with strain-based feedback governing growth in bone and suture tissues. A bulk bone formation approach accounts for evolving mechanical properties, with elastic moduli of bone and sutures increasing monthly. The model was applied on individual fused sutures and skull dysmorphologies due to craniosynostosis were predicted, and results showed good agreement with clinically observations. Stress at bone-suture interfaces and elevated intracranial pressure under fused sutures highlighted biomechanical impacts due to the disorders. Sensitivity analysis explored how material properties and growth rates affect skull shape. This framework enhances understanding of cranial growth and supports treatment planning for craniosynostosis.2025-10-17T12:15:13Z24 Pages, 10 Figure, 5 TablesMahtab VafaeefarConall QuinnTed J. Vaughanhttp://arxiv.org/abs/2510.12584v1Recent Advances in Microfluidics and Bioelectronics for Three-Dimensional Organoid Interfaces2025-10-14T14:40:44ZOrganoids offer a promising alternative in biomedical research and clinical medicine, with better feature recapitulation than 2D cultures. They also have more consistent responses with clinical results when compared to animal models. However, major challenges exist in the longevity of culture, the reproducibility of organoid properties, and the development of non-disruptive monitoring methods. Recent advances in materials and microfabrication methods, such as 3D printing and compressive buckling, have enabled three-dimensional (3D) interfaces of microfluidics and bioelectronics to manipulate and monitor these biological models in exciting ways. These advanced systems have great potential for applications in drug delivery, personalized medicine, and disease modelling. We conclude with important future considerations to generate longevity using further technological development in organoid and spheroid models.2025-10-14T14:40:44ZCaroline FergusonYan LiYi ZhangXueju Wanghttp://arxiv.org/abs/2412.12965v2The IBEX Imaging Knowledge-Base: A Community Resource Enabling Adoption and Development of Immunofluoresence Imaging Methods2025-10-12T19:21:59ZThe iterative bleaching extends multiplexity (IBEX) Knowledge-Base is a central portal for researchers adopting IBEX and related 2D and 3D immunofluorescence imaging methods. The design of the Knowledge-Base is modeled after efforts in the open-source software community and includes three facets: a development platform (GitHub), static website, and service for data archiving. The Knowledge-Base facilitates the practice of open science throughout the research life cycle by providing validation data for recommended and non-recommended reagents, such as primary and secondary antibodies. In addition to reporting negative data, the Knowledge-Base empowers method adoption and evolution by providing a venue for sharing protocols, videos, datasets, software, and publications. A dedicated discussion forum fosters a sense of community among researchers while addressing questions not covered in published manuscripts. Together, scientists from around the world are advancing scientific discovery at a faster pace, reducing wasted time and effort, and instilling greater confidence in the resulting data.2024-12-17T14:50:34ZZiv YanivBioinformatics and Computational Bioscience Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USAIfeanyichukwu U. AnidiCritical Care Medicine and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USALeanne ArakkalLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAArmando J. Arroyo-MejíasLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USARebecca T. BeuschelLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAKaty BörnerDepartment of Intelligent Systems Engineering, Indiana University, Bloomington, IN, USAColin J. ChuUCL Institute of Ophthalmology and NIHR Moorfields Biomedical Research Centre, London, UKBeatrice ClarkLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAMenna R. ClatworthyCambridge Institute for Therapeutic Immunology and Infectious Diseases, University of Cambridge Department of Medicine, Molecular Immunity Unit, Laboratory of Molecular Biology, Cambridge, UKJake ColauttiMcMaster Immunology Research Centre, Schroeder Allergy and Immunology Research Institute, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaFabian CosciaMax-Delbrueck-Center for Molecular Medicine in the Helmholtz AssociationJoshua CroteauDepartment of Business Development, BioLegend Inc., San Diego, CA, USASaven DenhaMcMaster Immunology Research Centre, Schroeder Allergy and Immunology Research Institute, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaRose DeverFunctional Immunogenomics Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USAWalderez O. DutraLaboratory of Cell-Cell Interactions, Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilSonja FritzscheMax-Delbrueck-Center for Molecular Medicine in the Helmholtz AssociationHumboldt-Universitat zu Berlin, Institute of Biology, Berlin, GermanySpencer FullamDivision of Rheumatology, Rush University Medical Center, Chicago, IL, USAMichael Y. GernerDepartment of Immunology, University of Washington School of Medicine, Seattle, WA, USAAnita GolaRobin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, The Rockefeller University, New York, NY, USAKenneth J. GollobCenter for Research in Immuno-oncologyJonathan M. HernandezSurgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAJyh Liang HorLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAHiroshi IchiseLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAZhixin JingLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USADanny JonigkInstitute of Pathology, Aachen Medical University, RWTH Aachen, Aachen, GermanyGerman Center for Lung ResearchEvelyn KandovLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAWolfgang KastenmüllerWürzburg Institute of Systems Immunology, Max Planck Research Group at the Julius-Maximilians-Universität Würzburg, Würzburg, GermanyJoshua F. E. KoenigMcMaster Immunology Research Centre, Schroeder Allergy and Immunology Research Institute, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaAanandita KothurkarUCL Institute of Ophthalmology and NIHR Moorfields Biomedical Research Centre, London, UKRosa K. KortekaasDepartment of Medicine, McMaster University, Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, CanadaAlexandra Y. KreinsInfection Immunity and Inflammation Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, UKIan T. LambornLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAYuri LinSurgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAKatia Luciano Pereira MoraisCenter for Research in Immuno-oncologyAleksandra LunichCritical Care Medicine and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USAJean C. S. LuzViral Vector Laboratory, Cancer Institute of São Paulo, University of São Paulo, SP, BrazilRyan B. MacDonaldUCL Institute of Ophthalmology and NIHR Moorfields Biomedical Research Centre, London, UKChen MakranzNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAVivien I. MaltezDivision of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of California San Diego, La Jolla, CA, USAJohn E. McDonoughDepartment of Medicine, McMaster University, Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, CanadaRyan V. MoriartyDepartment of Cellular and Developmental Biology, Northwestern University, Chicago, IL, USAJuan M. Ocampo-GodinezInfection Immunity and Inflammation Research and Teaching Department, University College London Great Ormond Street Institute of Child Health, London, UKLaboratorio de Bioingeniería de Tejidos, Departamento de Estudios de Posgrado e Investigación, Universidad Nacional Autónoma de México, Mexico City, MexicoVitoria M. OlynthoMcMaster Immunology Research Centre, Schroeder Allergy and Immunology Research Institute, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaAnnette OxeniusInstitute of Microbiology, ETH Zurich, Zurich, SwitzerlandKartika PadhanLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USACenter for Advanced Tissue Imaging Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAKirsten RemmertSurgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USANathan RichozCambridge Institute for Therapeutic Immunology and Infectious Diseases, University of Cambridge Department of Medicine, Molecular Immunity Unit, Laboratory of Molecular Biology, Cambridge, UKEdward C. SchromLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAWanjing ShangLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USALihong ShiLaboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USARochelle M. ShihLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAEmily SperanzaFlorida Research and Innovation Center, Cleveland Clinic Lerner Research Institute, Port Saint Lucie, FL, USASalome StierliInstitute of Anatomy, University of Zurich, Zurich, SwitzerlandSarah A. TeichmannCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge Biomedical Campus, Cambridge, UKTibor Z. VeresLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAMegan VierhoutMcMaster Immunology Research Centre, Schroeder Allergy and Immunology Research Institute, Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaDepartment of Medicine, McMaster University, Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, CanadaBrianna T. WachterLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USAAdam K. Wade-VallanceLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAMargaret WilliamsCritical Care Medicine and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USANathan ZanggerInstitute of Microbiology, ETH Zurich, Zurich, SwitzerlandRonald N. GermainLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USACenter for Advanced Tissue Imaging Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USAAndrea J. RadtkeLymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USACenter for Advanced Tissue Imaging Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USALeica Microsystems, Wetzlar, Germanyhttp://arxiv.org/abs/2509.10554v5MAE-SAM2: Mask Autoencoder-Enhanced SAM2 for Clinical Retinal Vascular Leakage Segmentation2025-10-10T15:39:58ZWe propose MAE-SAM2, a novel foundation model for retinal vascular leakage segmentation on fluorescein angiography images. Due to the small size and dense distribution of the leakage areas, along with the limited availability of labeled clinical data, this presents a significant challenge for segmentation tasks. Our approach integrates a Self-Supervised learning (SSL) strategy, Masked Autoencoder (MAE), with SAM2. In our implementation, we explore different loss functions and conclude a task-specific combined loss. Extensive experiments and ablation studies demonstrate that MAE-SAM2 outperforms several state-of-the-art models, achieving the highest Dice score and Intersection-over-Union (IoU). Compared to the original SAM2, our model achieves a $5\%$ performance improvement, highlighting the promise of foundation models with self-supervised pretraining in clinical imaging tasks.2025-09-09T20:29:48ZXin XingIrmak KaracaAmir AkhavanrezayatSamira BadrlooQuan Dong NguyenMahadevan Subramaniamhttp://arxiv.org/abs/2509.06991v3Towards deep-learning based detection and quantification of intestinal metaplasia on digitized gastric biopsies: a multi-expert comparative study2025-10-10T13:36:32ZCurrent gastric cancer (GCa) risk systems are prone to errors since they evaluate a visual estimation of intestinal metaplasia percentages in histopathology images of gastric mucosa to assign a risk. This study presents an automated method to detect and quantify intestinal metaplasia using deep convolutional neural networks as well as a comparative analysis with visual estimations of three pathologists. Gastric samples were collected from two different cohorts: 149 asymptomatic volunteers from a region with a high prevalence of GCa in Colombia and 56 patients from a tertiary hospital. Deep learning models were trained to classify intestinal metaplasia, and predictions were used to estimate a percentage of intestinal metaplasia and to assign an adapted OLGIM stage. Atrophy was not assessed because of the limited reproducibility among pathologists. Results were compared with independent blinded metaplastic assessments performed by three graduated pathologists. The best-performing deep learning architecture classified intestinal metaplasia with F1-Score of 0.80 +- 0.01 and AUC of 0.91 +- 0.01. Among pathologists, inter-observer agreement by a Fleiss's Kappa score ranged from 0.20 to 0.48. In comparison, agreement between the pathologists and the best-performing model ranged from 0.12 to 0.35. Deep learning models show potential to reliably detect and quantify the percentage of intestinal metaplasia, achieving high classification performance. In practice, visual estimation is still the only available method, yet it is marked by considerable inter-observer variability. Deep learning models provide consistent estimates that could help reduce this subjectivity in risk stratification.2025-09-02T18:56:57Z15 pages, 6 figures, 2 tablesFabian CanoMauricio CaviedesAndres SiabattoJesus VillarrealJose QuijanoÁlvaro Bedoya-UrrestaMarino Coral BedoyaYomaira Yepez CaicedoAngel Cruz-RoaFabio A. GonzálezSatish E. ViswanathEduardo Romerohttp://arxiv.org/abs/2411.00071v3What the %PCSA? Addressing Diversity in Lower-Limb Musculoskeletal Models: Age- and Sex-related Differences in PCSA and Muscle Mass2025-10-10T13:15:20ZMusculoskeletal (MSK) models offer a non-invasive way to understand biomechanical loads on joints and tendons, which are difficult to measure directly. Variations in muscle strength, especially relative differences between muscles, significantly impact model outcomes. Typically, scaled generic MSK models use maximum isometric forces that are not adjusted for different demographics, raising concerns about their accuracy. This review provides an overview on experimentally derived strength parameters, including physiological cross-sectional area (PCSA), muscle mass (Mm), and relative muscle mass (%Mm), which is the relative distribution of muscle mass across the leg. We analysed differences by age and sex, and compared open-source lower limb MSK model parameters with experimental data from 57 studies. Our dataset, with records dating back to 1884, shows that uniformly increasing all maximum isometric forces in MSK models does not capture key muscle ratio differences due to age and sex. Males have a higher proportion of muscle mass in the rectus femoris and semimembranosus muscles, while females have a greater relative muscle mass in the pelvic (gluteus maximus and medius) and ankle muscles (tibialis anterior, tibialis posterior, and extensor digitorum longus). Older adults have a higher relative muscle mass in the gluteus medius, while younger individuals show more in the gastrocnemius. Current MSK models do not accurately represent muscle mass distribution for specific age or sex groups, and none of them accurately reflect female muscle mass distribution. Further research is needed to explore musculotendon age- and sex differences.2024-10-31T15:58:38ZR. MaarleveldH. E. J. VeegerF. C. T. van der HelmJ. SonR. L. LieberE. van der Krukhttp://arxiv.org/abs/2510.08407v1Biology-driven assessment of deep learning super-resolution imaging of the porosity network in dentin2025-10-09T16:26:38ZThe mechanosensory system of teeth is currently believed to partly rely on Odontoblast cells stimulation by fluid flow through a porosity network extending through dentin. Visualizing the smallest sub-microscopic porosity vessels therefore requires the highest achievable resolution from confocal fluorescence microscopy, the current gold standard. This considerably limits the extent of the field of view to very small sample regions. To overcome this limitation, we tested different deep learning (DL) super-resolution (SR) models to allow faster experimental acquisitions of lower resolution images and restore optimal image quality by post-processing. Three supervised 2D SR models (RCAN, pix2pix, FSRCNN) and one unsupervised (CycleGAN) were applied to a unique set of experimentally paired high- and low-resolution confocal images acquired with different sampling schemes, resulting in a pixel size increase of x2, x4, x8. Model performance was quantified using a broad set of similarity and distribution-based image quality assessment (IQA) metrics, which yielded inconsistent results that mostly contradicted our visual perception. This raises the question of the relevance of such generic metrics to efficiently target the specific structure of dental porosity. To resolve this conflicting information, the generated SR images were segmented taking into account the specific scales and morphology of the porosity network and analysed by comparing connected components. Additionally, the capacity of the SR models to preserve 3D porosity connectivity throughout the confocal image stacks was evaluated using graph analysis. This biology-driven assessment allowed a far better mechanistic interpretation of SR performance, highlighting differences in model sensitivity to weak intensity features and the impact of non-linearity in image generation, which explains the failure of standard IQA metrics.2025-10-09T16:26:38ZLauren AndersonLucas ChatelainNicolas TremblayKathryn GrandfieldDavid RousseauAurélien Gourrierhttp://arxiv.org/abs/2307.07943v2Panoramic Voltage-Sensitive Optical Mapping of Contracting Hearts using Cooperative Multi-View Motion Tracking with 12 to 24 Cameras2025-10-09T15:00:03ZVoltage-sensitive fluorescence imaging is widely used to image action potential waves in the heart. However, while the electrical waves trigger mechanical contraction, imaging needs to be performed with pharmacologically contraction-inhibited hearts, limiting studies of the coupling between cardiac electrophysiology and tissue mechanics. Here, we introduce a high-resolution multi-camera optical mapping system with which we image action potential waves at high resolutions across the entire ventricular surface of the beating and strongly deforming heart. We imaged intact isolated rabbit hearts inside a soccer-ball shaped imaging chamber facilitating even illumination and panoramic imaging. Using 12 high-speed cameras, ratiometric voltage-sensitive imaging, and three-dimensional (3D) multi-view motion tracking, we reconstructed the entire 3D deforming ventricular surface and performed corresponding voltage-sensitive measurements during sinus rhythm, paced rhythm, and ventricular fibrillation. Our imaging setup defines a new state-of-the-art in the field and can be used to study the heart's electromechanical physiology during health and disease at unprecedented resolutions. For instance, we measured electrical activation times and observed mechanical strain waves following electrical activation fronts during pacing, observed electromechanical vortices during ventricular fibrillation, and measured action potential duration and contractile changes in response to pharmacological blockage of potassium ion channels.2023-07-16T04:31:30ZCardiovascular Research, Biophysics, Biomedical Engineering, Optics, Physics, Computer VisionShrey ChowdharyJan LebertShai DickmanCharles GordonJan Christoph10.1113/JP290533http://arxiv.org/abs/2510.07657v1Upconverting microgauges reveal intraluminal force dynamics in vivo2025-10-09T01:24:46ZThe forces generated by action potentials in muscle cells shuttle blood, food and waste products throughout the luminal structures of the body. Although non-invasive electrophysiological techniques exist, most mechanosensors cannot access luminal structures non-invasively. Here we introduce non-toxic ingestible mechanosensors to enable the quantitative study of luminal forces and apply them to study feeding in living Caenorhabditis elegans roundworms. These optical 'microgauges' comprise NaY0.8Yb0.18Er0.02F4@NaYF4 upconverting nanoparticles embedded in polystyrene microspheres. Combining optical microscopy and atomic force microscopy to study microgauges in vitro, we show that force evokes a linear and hysteresis-free change in the ratio of emitted red to green light. With fluorescence imaging and non-invasive electrophysiology, we show that adult C. elegans generate bite forces during feeding on the order of 10 micronewtons and that the temporal pattern of force generation is aligned with muscle activity in the feeding organ. Moreover, the bite force we measure corresponds to Hertzian contact stresses in the pressure range used to lyse the bacterial food of the worm. Microgauges have the potential to enable quantitative studies that investigate how neuromuscular stresses are affected by aging, genetic mutations and drug treatments in this organ and other luminal organs.2025-10-09T01:24:46Z18 pages, 4 figuresNature 637, 76-83 (2025)Jason R. CasarClaire A. McLellanCindy ShiAriel StiberAlice LayChris SiefeAbhinav ParakhMalaya GaerlanX. Wendy GuMiriam B. GoodmanJennifer A. Dionne10.1038/s41586-024-08331-xhttp://arxiv.org/abs/2510.07072v1A model of the human cornea as a hydrated, fluid-saturated medium2025-10-08T14:34:34ZWe introduce a new model of the human corneal stroma, regarded as a fluid-saturated continuum, able to describe surface flattening and thickness thinning observed in several pathological conditions. In contrast with more common approaches that describe the human cornea as a quasi-incompressible hyperelastic medium, eventually including micro-structured anisotropy and heterogeneity, here we focus on the multi-phase nature of the tissue, where the content of water reaches about 78\% in weight. The study is motivated by the fact that, although purely mechanical continuum models have been demonstrated to be satisfactory and accurate at predicting physiological behaviors, they have not been able to capture the geometrical features of tissue degeneration clearly associated to a reduction of the fluid content in the stroma, such thinning and loss of curvature. Here, we model the cornea as a fully saturated mixture of a solid phase and a fluid phase, in principle without restricting the formulation to specific assumptions on the actual inhomogeneous nature of both phases. The focus of the study is to understand whether a multiphysics model is capable of explaining, in terms of fluid flux imbalance, such as ectasia and keratoconus. As a first attempt in this direction, we make simple isotropic constitutive assumptions for both phases.2025-10-08T14:34:34ZA. GiammariniA. Pandolfi10.1016/j.mechmat.2025.105586http://arxiv.org/abs/2411.06539v2Advancing glaucoma research with multiphysics continuum mechanics modelling: Opportunities and open challenges2025-10-07T19:12:34ZThis review examines the emerging role of mechanistic mathematical models based on continuum mechanics to address current challenges in glaucoma research. At present, the advent of Artificial Intelligence and data-based models have resulted in significant progress in drug candidate screening, target identification and delivery optimization for glaucoma treatment. Physics-based models on the other hand offer mechanistic insight by modelling fundamental physical knowledge. Mechanistic models, and specifically those based on continuum mechanics, have the potential to contribute to a better understanding of glaucoma through the description of intraocular fluid dynamics, mass and heat transfer and other basic physical phenomena. So far, these models have expanded our understanding of ocular fluid dynamics, including descriptions of fluid flow profiles within the anterior chamber of the eye under glaucomatous conditions. With the ongoing development of multiphysics modelling frameworks, there is increasing potential to apply these tools to a wide range of current challenges within the field of glaucoma research. These challenges include glaucoma drainage devices, minimally invasive surgical procedures, therapeutic contact lenses, laser-based interventions like peripheral iridotomy, and the design and optimization of biodegradable drug-releasing intracameral implants, which support patient-specific strategies for glaucoma diagnosis and treatment2024-11-10T17:41:37ZDaniel Sebastia-SaezJinyuan LuoMengqi QinTao ChenCynthia Yu-Wai-Manhttp://arxiv.org/abs/2510.05083v1Robust multicellular programs dissect the complex tumor microenvironment and track disease progression in colorectal adenocarcinomas2025-10-06T17:51:26ZColorectal cancer (CRC) is highly heterogeneous, with five-year survival rates dropping from $\sim$90% in localized disease to $\sim$15% with distant metastases. Disease progression is shaped not only by tumor-intrinsic alterations but also by the reorganization of the tumor microenvironment (TME). Metabolic, compositional, and spatial changes contribute to this progression, but considered individually they lack context and often fail as therapeutic targets. Understanding their coordination could reveal processes to alter the disease course. Here, we combined multiplexed ion beam imaging (MIBI) with machine learning to profile metabolic, functional and spatial states of 522 colorectal lesions with single-cell resolution. We observed recurrent stage-specific remodeling marked by a lymphoid-to-myeloid shift, stromal-cancer cooperation, and malignant metabolic shifts. Spatial organization of epithelial, stromal, and immune compartments provided stronger stratification of disease stage than tumor-intrinsic changes or bulk immune infiltration alone. To systematically model these coordinated changes, we condensed multimodal features into 10 latent factors of TME organization. These factors tracked disease progression, were conserved across cohorts, and revealed frequent multicellular metabolic niches and distinct, non-exclusive TME trajectories. Our framework MuVIcell exposes the elements that together drive CRC progression by grouping co-occurring changes across cell types and feature classes into coordinated multicellular programs. This creates a rational basis to therapeutically target TME reorganization. Importantly, the framework is scalable and flexible, offering a resource for studying multicellular organization in other solid tumors.2025-10-06T17:51:26ZLoan VulliardTeresa GlaunerSven TruxaMiray CetinYu-Le WuRonald SimonLaura BehmJovan TanevskiJulio Saez-RodriguezGuido SauterFelix J. Hartmannhttp://arxiv.org/abs/2510.19826v1Neurotremor: A wearable Supportive Device for Supporting Upper Limb Muscle Function2025-10-02T00:07:09ZA sensor-fused wearable assistance prototype for upper-limb function (triceps brachii and extensor pollicis brevis) is presented. The device integrates surface electromyography (sEMG), an inertial measurement unit (IMU), and flex/force sensors on an M5StickC plus an ESP32-S3 compute hub. Signals are band-pass and notch filtered; features (RMS, MAV, zero-crossings, and 4-12 Hz tremor-band power) are computed in 250 ms windows and fed to an INT8 TensorFlow Lite Micro model. Control commands are bounded by a control-barrier-function safety envelope and delivered within game-based tasks with lightweight personalization. In a pilot technical feasibility evaluation with healthy volunteers (n = 12) performing three ADL-oriented tasks, tremor prominence decreased (Delta TI = -0.092, 95% CI [-0.102, -0.079]), range of motion increased (+12.65%, 95% CI [+8.43, +13.89]), repetitions rose (+2.99 min^-1, 95% CI [+2.61, +3.35]), and the EMG median-frequency slope became less negative (Delta = +0.100 Hz/min, 95% CI [+0.083, +0.127]). The sensing-to-assist loop ran at 100 Hz with 8.7 ms median on-device latency, 100% session completion, and 0 device-related adverse events. These results demonstrate technical feasibility of embedded, sensor-fused assistance for upper-limb function; formal patient studies under IRB oversight are planned.2025-10-02T00:07:09Z6 pages, 3 figures, 13 equations, 2 tableAueaphum AueawattthanaphisutThanyanee SrichaisakArissa Ieochai